Penelope Health raises $100M for real-time payer policy intelligence

Penelope Health, the London-founded health policy intelligence startup, has secured a $100 million (€87 million) funding commitment led by Thoreau, with Bertelsmann Healthcare Investments, Twine Ventures and Seedcamp participating, announced on 18 September 2026 – one year after the company was incorporated.

European digital health does not see many nine-figure commitments, and the ones it does see usually reward a decade of grind. This one landed twelve months in. The good news is that it is not an anomaly – it is the second $100 million cheque written to a European-founded health company in a single week. Below, I lay out the round, the product behind it, the market it sells into and the pattern the two cheques confirm.

One hundred million dollars for the small print

Thoreau, along with the round’s other investors, has committed $100 million in funding to Penelope Health, per the company’s 18 September announcement. Bertelsmann Healthcare Investments, Twine Ventures and Seedcamp join the commitment; Seedcamp has backed the company since its first round. No stage label is attached – this is a commitment, not a lettered round.

The money goes to new products for administrative efficiency, wider insurer and policy coverage, and moving coverage determination upstream to the point of care, in the company’s words.

The lead deserves a second look. Thoreau is not a conventional venture fund but a healthcare technology platform that creates, invests in and acquires companies across provider, payer, employer, life sciences and government markets. Its first platform partnership, Ensemble Health, manages over $55 billion in net patient revenue; Penelope Health is named as its second. When a buyer-operator of that size leads your round, the line between financing and distribution starts to blur – and that is precisely the point.

From London wards to American payer rulebooks

So how does a twelve-month-old company earn that kind of backing? Penelope Health was founded in 2025 by Dr Sohum Patel and Mattijs De Paepe. Patel practised in inpatient and outpatient settings across the Royal Free London and University College London hospital systems; De Paepe spent nearly four years building machine learning systems at Via Transportation. A doctor who has lived the paperwork and an engineer who has automated messier networks than this – it is a fair pairing for the job.

The product tracks the coverage rules US health insurers publish – prior authorisation requirements, medical necessity criteria, coding rules – and turns them into structured data that providers and payers use directly, through an API and through endpoints AI assistants can query. The platform already covers policies governing coverage for more than 200 million insured Americans, spanning more than 15,000 procedure and drug codes, per the company.

“The rules that determine whether care is covered by insurance are foundational to the healthcare system, yet remain opaque and constantly changing,” is how Patel frames it in the announcement. Anyone who has waited on a prior authorisation will not argue.

A $7.8 billion market compounding at 7.3%

The segment Penelope Health sells into is measurable. Technology solutions in the US healthcare payer market were worth $7.8 billion in 2023 and are forecast to grow at a 7.3% CAGR from 2024 to 2030, reaching $12.6 billion – Grand View Research, February 2024. Claims management, the application closest to Penelope’s rules layer, held 32.2% of that market’s application segment in 2023, the largest share.

For scale, from our own records: the typical European digital health round this month is a single-digit seed – Aitiologic raised €6.4 million led by Heal Capital on 17 September, Health Force €4.2 million led by LUMO Labs the same day. Tandem Health’s $100 million Series B, announced on 14 September, was the outlier. Penelope Health makes it two outliers in one week. The running picture is in our fundraising data.

Two nine-figure health cheques in one week

What we are seeing is European-founded health companies raising American-sized money without becoming American companies first. Tandem Health took its $100 million from the EU’s scaleup fund in Stockholm; Penelope Health took its commitment from a US healthcare platform while its founders came out of London hospitals and a London seed fund. The capital sources could not be more different; the conviction is the same.

The other thing to watch is Thoreau’s model itself. Platform investors that create, invest and acquire – rather than simply write cheques – have long been a fixture of US private markets. A European-founded company as the second partnership on such a platform is a data point worth tracking: if the model repeats, the next European payer-infrastructure founders will have a new kind of term sheet to weigh.

One year from incorporation to $100 million, on rules nobody can read. The companies turning healthcare’s small print into infrastructure are being funded at pace. Watch this layer – it is where the next few nine-figure cheques are already pointed.